Literature DB >> 8543643

Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies.

R A Veenendaal1, J M Götz, V Schroijen, F Kurban, A T Bernards, M Veselic, A S Peña, C B Lamers.   

Abstract

AIMS: To investigate the diagnostic value of mucosal IgA and IgG Helicobacter pylori antibodies.
METHODS: The study population comprised 209 consecutive patients with severe dyspeptic complaints referred for upper gastrointestinal endoscopy. A positive culture or histological identification of H pylori in gastric biopsy specimens, or both, were used to confirm infection. Specific IgA and IgG H pylori antibodies were determined using a modified ELISA technique.
RESULTS: Of the 209 patients, 137 were infected with H pylori. The diagnostic value of systemic IgA and IgG H pylori antibodies was confirmed. Systemic IgA antibodies had a sensitivity of 76.6% (95% confidence interval 69.5-83.7) and a specificity of 94.4% (89.1-99.7). The sensitivity and specificity for systemic IgG antibodies were, respectively, 97.1% (94.3-99.9) and 98.6% (95.9-100). A moderate but clinically important correlation was found between local and systemic IgA and IgG. Mucosal IgA H pylori antibodies had a sensitivity of 98.5% (96.5-100) and a specificity of 91.7% (85.3-98.1), while for IgG these figures were, respectively, 88.3% (82.9-93.7) and 98.6% (95.9-100). As a diagnostic test mucosal IgA H pylori antibodies were comparable with culture and histology.
CONCLUSION: Determination of local IgA and IgG H pylori antibody levels is a highly sensitive and specific test for the diagnosis of H pylori infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543643      PMCID: PMC502999          DOI: 10.1136/jcp.48.11.990

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Duodenal ulcer: the villain unmasked?

Authors:  A R Axon
Journal:  BMJ       Date:  1991-04-20

2.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

3.  Treatment of peptic ulcers caused by Helicobacter pylori.

Authors:  D Y Graham
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

4.  Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

Authors:  D Y Graham; G M Lew; P D Klein; D G Evans; D J Evans; Z A Saeed; H M Malaty
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

5.  Long term serological surveillance after treatment of Helicobacter pylori infection.

Authors:  R A Veenendaal; A S Peña; J L Meijer; H P Endtz; M M van der Est; W van Duijn; F Eulderink; J Kreuning; C B Lamers
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

6.  Observer homogeneity in the histologic diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient, and repeat frequency.

Authors:  A H Christensen; T Gjørup; J Hilden; C Fenger; B Henriksen; M Vyberg; K Ostergaard; B F Hansen
Journal:  Scand J Gastroenterol       Date:  1992-11       Impact factor: 2.423

7.  Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.

Authors:  T U Kosunen; K Seppälä; S Sarna; P Sipponen
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

8.  Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer.

Authors:  R Sierra; N Muñoz; A S Peña; I Biemond; W van Duijn; C B Lamers; S Teuchmann; S Hernandez; P Correa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Sep-Oct       Impact factor: 4.254

9.  Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole.

Authors:  G Oderda; D Vaira; C Ainley; J Holton; J Osborn; F Altare; N Ansaldi
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy.

Authors:  R M Genta; H W Hamner; D Y Graham
Journal:  Hum Pathol       Date:  1993-06       Impact factor: 3.466

View more
  6 in total

1.  Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection.

Authors:  I Ahlstedt; C Lindholm; H Lönroth; A Hamlet; A M Svennerholm; M Quiding-Järbrink
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Human gastric B cell responses can be induced by intestinal immunisation.

Authors:  M Quiding-Järbrink; H Lönroth; I Ahlstedt; J Holmgren; A M Svennerholm
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

3.  Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites.

Authors:  S Futagami; H Takahashi; Y Norose; M Kobayashi
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

4.  Local and systemic immune and inflammatory responses to Helicobacter pylori strains.

Authors:  Niranjan Bhat; James Gaensbauer; Richard M Peek; Karen Bloch; Kyi-Toe Tham; Martin J Blaser; Guillermo Perez-Perez
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

Review 5.  Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches.

Authors:  Amin Talebi Bezmin Abadi
Journal:  J Pathog       Date:  2018-05-22

Review 6.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.